IPG Appoints President and CEO

Alpharetta, Ga.-based IPG, which provides surgical and implant cost management solutions, has named Vince Coppola as the company’s president and CEO effective March 31. In the role, Coppola will look to advance the company’s growth and evolution, while further building out its customer base and product portfolio.

Coppola most recently served as President and CEO of Triad, a musculoskeletal care management company. After leading the company in significant growth and profitability, Coppola stayed on as CEO with the company after the acquisition by MedSolutions in 2013 to assist in a successful integration and its continued growth. Coppola’s previous experience includes serving as the vice president of strategy and business development at Blue Shield of California, where he developed strategies to increase the company’s market position and competitiveness. Earlier, he served as senior vice president, corporate development of Magellan Health Services where he developed and executed a plan to successfully expand into radiology and specialty pharmacy. Coppola also held leading positions at United Health Group, Cigna, JP Morgan Chase and GE Capital.

“This is an opportune time for Vince to become IPG’s CEO, and we are delighted to have him join the team,” said Dennis Antinori, executive chairman of the board for IPG. “ Vince not only brings a high level of healthcare and payer experience integral to our business, but brings specific experience in the healthcare services arena and a proven track record of rapidly and successfully growing the companies he has been associated with. Vince truly stood apart as a leader, with his extraordinary ability to connect vision, people and innovation to drive strategy and success, and we look forward to his leadership at IPG.”

IPG experienced over a 60 percent growth rate last year, and is continuing that growth and momentum partnering with all of the major payers across the country to successfully drive down health care costs while ensuring quality of care for consumers.

“I wanted to be a part of a company that has the capabilities to drive quality and value for all healthcare stakeholders. Today, I am even more convinced that IPG is that company,” said Coppola. “Over the past 10 years, the vision and leadership of the company have built IPG into one of the most innovative companies in healthcare and the clear leader in the surgical and implant cost management business. The opportunity that lies ahead for IPG is enormous, and the ability to lead this next chapter is both humbling and exhilarating. I am focused on accelerating the innovation and execution that our customers need from us. Their success will continue to drive us and I am confident in our ability to win, and honored to lead this great company.”

IPG delivers a customized, data-driven approach to enable its health plan partners to manage their surgical and implant costs more effectively.